[HTML][HTML] Cytokines in inflammatory disease
This review aims to briefly discuss a short list of a broad variety of inflammatory cytokines.
Numerous studies have implicated that inflammatory cytokines exert important effects with …
Numerous studies have implicated that inflammatory cytokines exert important effects with …
[HTML][HTML] Current knowledge of bone-derived factor osteocalcin: its role in the management and treatment of diabetes mellitus, osteoporosis, osteopetrosis and …
M Martiniakova, R Biro, V Kovacova… - Journal of Molecular …, 2024 - Springer
Osteocalcin (OC) is the most abundant non-collagenous and osteoblast-secreted protein in
bone. It consists of two forms such as carboxylated OC (cOC) and undercarboxylated OC …
bone. It consists of two forms such as carboxylated OC (cOC) and undercarboxylated OC …
[HTML][HTML] miRNAs in bone tissue correlate to bone mineral density and circulating miRNAs are gender independent in osteoporotic patients
S Kelch, ER Balmayor, C Seeliger, H Vester… - Scientific reports, 2017 - nature.com
We previously demonstrated the aberrant expression of nine specific miRNAs in serum from
osteoporotic patients. In the present study, we further evaluated the expression of these …
osteoporotic patients. In the present study, we further evaluated the expression of these …
[HTML][HTML] Inflammation as a contributing factor among postmenopausal Saudi women with osteoporosis
Postmenopausal osteoporosis is an important metabolic bone disease characterized by
rapid bone loss occurring in the postmenopausal period. Recently, the most prevalent form …
rapid bone loss occurring in the postmenopausal period. Recently, the most prevalent form …
Associations between inflammatory mediators and bone outcomes in postmenopausal women: a cross-sectional analysis of baseline data from the prune study
Purpose Hypoestrogenism triggers increased production of inflammatory mediators, which
contribute to bone loss during postmenopausal osteoporosis. This study aimed to …
contribute to bone loss during postmenopausal osteoporosis. This study aimed to …
[HTML][HTML] A meta-analysis of serum osteocalcin level in postmenopausal osteoporotic women compared to controls
Z Liu, R Chen, Y Jiang, Y Yang, L He, C Luo… - BMC musculoskeletal …, 2019 - Springer
Background Circulatory osteocalcin (OC) has been widely used as a biomarker to indicate
bone turnover status in postmenopausal osteoporosis (PMO). However, the change of …
bone turnover status in postmenopausal osteoporosis (PMO). However, the change of …
Monotropein isolated from the roots of Morinda officinalis increases osteoblastic bone formation and prevents bone loss in ovariectomized mice
Z Zhang, Q Zhang, H Yang, W Liu, N Zhang, L Qin… - Fitoterapia, 2016 - Elsevier
Monotropein is a natural iridoid glycoside enriched in Morinda officinalis and has been used
for medicinal purposes in China. In the present study, we systematically examined its effects …
for medicinal purposes in China. In the present study, we systematically examined its effects …
[HTML][HTML] Association of RANKL and OPG Gene Polymorphism in Arab Women with and without Osteoporosis
Receptor activator of the nuclear factor-κB ligand (RANKL) and osteoprotegerin genes
(OPG) were identified as susceptible loci for postmenopausal osteoporosis (PMO) in various …
(OPG) were identified as susceptible loci for postmenopausal osteoporosis (PMO) in various …
[HTML][HTML] Associations of long chain polyunsaturated fatty acids with bone mineral density and bone turnover in postmenopausal women
O Feehan, PJ Magee, LK Pourshahidi… - European Journal of …, 2023 - Springer
Purpose The immunomodulatory properties of n-3 long chain polyunsaturated fatty acids
(LCPUFA) are reported to reduce bone loss through alteration of bone remodelling and n-3 …
(LCPUFA) are reported to reduce bone loss through alteration of bone remodelling and n-3 …
Biochemical changes associated with temporomandibular disorders
CY Demir, ME Ersoz - Journal of International Medical …, 2019 - journals.sagepub.com
Objective To assess vitamin D, parathyroid hormone, calcitonin, calcium, phosphorus and
magnesium levels in patients with versus without temporomandibular disorders (TMDs) …
magnesium levels in patients with versus without temporomandibular disorders (TMDs) …